These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 1717126)
1. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126 [TBL] [Abstract][Full Text] [Related]
2. AFP, CEA, CA 19-9 and TPA in hepatocellular carcinoma. Maussier ML; Valenza V; Schinco G; Galli G Int J Biol Markers; 1990; 5(3):121-6. PubMed ID: 1704905 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452 [TBL] [Abstract][Full Text] [Related]
4. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis. Sarwar S; Khan AA; Tarique S J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma. Li J; Tao H; Zhang E; Huang Z Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988 [TBL] [Abstract][Full Text] [Related]
6. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
7. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein. Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192 [TBL] [Abstract][Full Text] [Related]
8. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma? Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG Oncology; 1989; 46(6):381-5. PubMed ID: 2479897 [TBL] [Abstract][Full Text] [Related]
9. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667 [TBL] [Abstract][Full Text] [Related]
10. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240 [TBL] [Abstract][Full Text] [Related]
11. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [TBL] [Abstract][Full Text] [Related]
12. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352 [TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis. Leandro G; Basso D; Fabris C; Zizzari S; Elba S; Del Favero G; Di Mario F; Meggiato T; Angonese C; Naccarato R J Cancer Res Clin Oncol; 1989; 115(3):276-8. PubMed ID: 2473990 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [TBL] [Abstract][Full Text] [Related]
15. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. Wang M; Devarajan K; Singal AG; Marrero JA; Dai J; Feng Z; Rinaudo JA; Srivastava S; Evans A; Hann HW; Lai Y; Yang H; Block TM; Mehta A Cancer Prev Res (Phila); 2016 Feb; 9(2):172-9. PubMed ID: 26712941 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis. Worland T; Harrison B; Delmenico L; Dowling D J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172 [TBL] [Abstract][Full Text] [Related]
17. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein. Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611 [TBL] [Abstract][Full Text] [Related]
18. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development]. Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920 [TBL] [Abstract][Full Text] [Related]
19. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733 [TBL] [Abstract][Full Text] [Related]
20. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma. Lopez JB; Balasegaram M; Timor J; Thambyrajah V Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]